Stefan A Dyckerhoff
Director at Astera Labs, Inc. (ALAB)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $29.1M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 9 NewSEC | ALABAstera Labs, Inc. | Sell Plan | 3,50547,019 held (−7%) | $376.06 | $1.3M | -9.0% |
| Oct 9 NewSEC | ALABAstera Labs, Inc. | Sell Plan | 8,333286,400 held (−3%) | $376.06 | $3.1M | -9.0% |
| Oct 9 NewSEC | ALABAstera Labs, Inc. | Sell Plan | 6612,648 held (−20%) | $376.06 | $249K | -9.0% |
| Sep 3SEC | ALABAstera Labs, Inc. | Sell Plan | 27353,688 held (−1%) | $273.64 | $75K | +25.1% |
| Sep 3SEC | ALABAstera Labs, Inc. | Sell Plan | 650302,416 held (−0%) | $273.64 | $178K | +25.1% |
| Sep 3SEC | ALABAstera Labs, Inc. | Sell Plan | 523,918 held (−1%) | $273.64 | $14K | +25.1% |
| Sep 3SEC | ALABAstera Labs, Inc. | Sell Plan | 2,27551,413 held (−4%) | $274.79 | $625K | +24.5% |
| Sep 3SEC | ALABAstera Labs, Inc. | Sell Plan | 5,409297,007 held (−2%) | $274.79 | $1.5M | +24.5% |
| Sep 3SEC | ALABAstera Labs, Inc. | Sell Plan | 4293,489 held (−11%) | $274.79 | $118K | +24.5% |
| Sep 3SEC | ALABAstera Labs, Inc. | Sell Plan | 78550,628 held (−2%) | $275.53 | $216K | +24.2% |
| Sep 3SEC | ALABAstera Labs, Inc. | Sell Plan | 1,867295,140 held (−1%) | $275.53 | $514K | +24.2% |
| Sep 3SEC | ALABAstera Labs, Inc. | Sell Plan | 1483,341 held (−4%) | $275.53 | $41K | +24.2% |
| Sep 3SEC | ALABAstera Labs, Inc. | Sell Plan | 17250,456 held (−0%) | $276.75 | $48K | +23.7% |
| Sep 3SEC | ALABAstera Labs, Inc. | Sell Plan | 407294,733 held (−0%) | $276.75 | $113K | +23.7% |
| Sep 3SEC | ALABAstera Labs, Inc. | Sell Plan | 323,309 held (−1%) | $276.75 | $9K | +23.7% |
| Aug 10SEC | ALABAstera Labs, Inc. | Sell Plan | 1,02956,437 held (−2%) | $309.29 | $318K | +10.6% |
| Aug 10SEC | ALABAstera Labs, Inc. | Sell Plan | 2,447308,952 held (−1%) | $309.29 | $757K | +10.6% |
| Aug 10SEC | ALABAstera Labs, Inc. | Sell Plan | 1944,437 held (−4%) | $309.29 | $60K | +10.6% |
| Aug 10SEC | ALABAstera Labs, Inc. | Sell Plan | 26956,168 held (−0%) | $311.37 | $84K | +9.9% |
| Aug 10SEC | ALABAstera Labs, Inc. | Sell Plan | 640308,312 held (−0%) | $311.37 | $199K | +9.9% |
| Aug 10SEC | ALABAstera Labs, Inc. | Sell Plan | 514,386 held (−1%) | $311.37 | $16K | +9.9% |
| Aug 10SEC | ALABAstera Labs, Inc. | Sell Plan | 2,20753,961 held (−4%) | $313.07 | $691K | +9.3% |
| Aug 10SEC | ALABAstera Labs, Inc. | Sell Plan | 5,246303,066 held (−2%) | $313.07 | $1.6M | +9.3% |
| Aug 10SEC | ALABAstera Labs, Inc. | Sell Plan | 4163,970 held (−9%) | $313.07 | $130K | +9.3% |
| Jul 2SEC | ALABAstera Labs, Inc. | Sell Plan | 3,50557,466 held (−6%) | $450.00 | $1.6M | -24.0% |
| Jul 2SEC | ALABAstera Labs, Inc. | Sell Plan | 8,333311,399 held (−3%) | $450.00 | $3.7M | -24.0% |
| Jul 2SEC | ALABAstera Labs, Inc. | Sell Plan | 6614,631 held (−12%) | $450.00 | $297K | -24.0% |
| Jun 5SEC | ALABAstera Labs, Inc. | Sell Plan | 3,07760,562 held (−5%) | $364.25 | $1.1M | -6.1% |
| Jun 5SEC | ALABAstera Labs, Inc. | Sell Plan | 7,314320,751 held (−2%) | $364.25 | $2.7M | -6.1% |
| Jun 5SEC | ALABAstera Labs, Inc. | Sell Plan | 5805,373 held (−10%) | $364.25 | $211K | -6.1% |
| Jun 5SEC | ALABAstera Labs, Inc. | Sell Plan | 42860,134 held (−1%) | $365.09 | $156K | -6.3% |
| Jun 5SEC | ALABAstera Labs, Inc. | Sell Plan | 1,019319,732 held (−0%) | $365.09 | $372K | -6.3% |
| Jun 5SEC | ALABAstera Labs, Inc. | Sell Plan | 815,292 held (−2%) | $365.09 | $30K | -6.3% |
| May 11SEC | ALABAstera Labs, Inc. | Sell Plan | 1,78365,361 held (−3%) | $199.00 | $355K | +72.0% |
| May 11SEC | ALABAstera Labs, Inc. | Sell Plan | 4,238332,160 held (−1%) | $199.00 | $843K | +72.0% |
| May 11SEC | ALABAstera Labs, Inc. | Sell Plan | 3366,278 held (−5%) | $199.00 | $67K | +72.0% |
| May 11SEC | ALABAstera Labs, Inc. | Sell Plan | 1,72263,639 held (−3%) | $201.10 | $346K | +70.2% |
| May 11SEC | ALABAstera Labs, Inc. | Sell Plan | 4,095328,065 held (−1%) | $201.10 | $824K | +70.2% |
| May 11SEC | ALABAstera Labs, Inc. | Sell Plan | 3255,953 held (−5%) | $201.10 | $65K | +70.2% |
| Apr 21SEC | ALABAstera Labs, Inc. | Sell Plan | 3,25370,901 held (−4%) | $175.00 | $569K | +95.5% |
| Apr 21SEC | ALABAstera Labs, Inc. | Sell Plan | 7,733345,331 held (−2%) | $175.00 | $1.4M | +95.5% |
| Apr 21SEC | ALABAstera Labs, Inc. | Sell Plan | 6137,323 held (−8%) | $175.00 | $107K | +95.5% |
| Apr 21SEC | ALABAstera Labs, Inc. | Sell Plan | 3,75767,144 held (−5%) | $175.12 | $658K | +95.4% |
| Apr 21SEC | ALABAstera Labs, Inc. | Sell Plan | 8,933336,398 held (−3%) | $175.12 | $1.6M | +95.4% |
| Apr 21SEC | ALABAstera Labs, Inc. | Sell Plan | 7096,614 held (−10%) | $175.12 | $124K | +95.4% |
- Sell
Director Stefan A Dyckerhoff sold $1.3M of ALAB at $376.06 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Stefan A Dyckerhoff sold $3.1M of ALAB at $376.06 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Stefan A Dyckerhoff sold $249K of ALAB at $376.06 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Stefan A Dyckerhoff sold $75K of ALAB at $273.64 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Stefan A Dyckerhoff sold $178K of ALAB at $273.64 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Stefan A Dyckerhoff sold $14K of ALAB at $273.64 — pre-scheduled 10b5-1 plan sale.